Certain medications may require predefined criteria before being approved for coverage. Other drugs may have daily or monthly limits recommended by the Food and Drug Administration, the drugs manufacturer, and/or  peer-reviewed medical literature. These instances may require a doctors request for preapproval or prior authorization.

 

The following guidelines, developed by Blue Cross and Blue Shield of Alabama's Pharmacy and Therapeutics Committee, are meant to help members understand the requirements related to their pharmacy coverage. Healthcare providers should use their best medical judgment in providing the care they feel is most appropriate for their patients.

 

Please note: Some employer groups may have specific drug coverage requirements for their employees that are not included in the criteria below.

 

For more information please review Physician Administered Drug Policies.

Search by Drug Name

Product Name Implementation Date Change Date Guideline
EDARBI® 04/01/13 Edarbi may be subject to step therapy requirements. Patients must have trial and failure of both of the following: 1) generic ACE inhibitor or generic ARB, AND 2) preferred brand ARB (Diovan, Exforge/HCT, Micardis/HCT).
EDARBYCLOR® 04/01/13 Edarbyclor may be subject to step therapy requirements. Patients must have trial and failure of both of the following: 1) generic ACE inhibitor or generic ARB, AND 2) preferred brand ARB (Diovan, Exforge/HCT, Micardis/HCT).
EDEX® Prior authorization for medical necessity may be required. Patients must be at least 18 years of age.
EDLUAR® 07/01/13 The limits are 1 tablet per day.
EDURANT The limits are 1 tablet per day.
EFFEXOR XR® 02/13/08 The limits are 1 capsule per day, except Effexor XR 75mg which has a limit of 3 capsules per day.
ELIQUIS 10/01/14 The limits are 2 tablets per day for Eliquis 2.5mg and 4 tablets per day for Eliqus 5 mg.
EMBEDA® The limits are 2 capsules per day.
EMEND® 04/01/12 The limits are 4 capsules per 30 days for Emend 80mg, 2 capsules per 30 days for Emend 125mg, and 2 packs (6 capsules) per 30 days for Emend 125mg/80mg packs.
EMTRIVA The limits are 1 capsule or 24 mL per day.
ENBREL® 01/01/14 Enbrel may be subject to step therapy requirements. Patients must have trial and failure of a first-line DMARD. The limits are 8 doses of Enbrel 25mg or 4 doses of Enbrel 50mg per 28 days.
ENDOCET®
EPIDUO® Prior authorization for medical necessity may be required.
EPIVIR 04/01/15 The limits are 2 tablets for Epivir 150 mg, 1 tablet for Epivir 300 mg or 960 ml/month for Epivir solution.
EPZICOM The limits are 1 tablet per day.

Affordable Care Act

Healthcare Reform Questions? Learn More

HealthQuotient®

What's your HQ Score? Get Started Now!